Petr Sedláček
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 38
- Chronic Myeloid Leukemia Treatments 27
- Acute Myeloid Leukemia Research 22
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
-
- Acute Lymphoblastic Leukemia research 35
- Immunology top 10%
- Immune Cell Function and Interaction 9
- Epidemiology top 10%
- Cytomegalovirus and herpesvirus research 13
-
- Childhood Cancer Survivors' Quality of Life 8
Petr Sedláček
101 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 79
- Hematology 867
- Genetics 250
- Public Health, Environmental and Occupational Health 467
- Immunology 287
- Epidemiology 406
Countries citing papers authored by Petr Sedláček
This map shows the geographic impact of Petr Sedláček's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Sedláček with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Sedláček more than expected).
Fields of papers citing papers by Petr Sedláček
This network shows the impact of papers produced by Petr Sedláček. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Sedláček. The network helps show where Petr Sedláček may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Petr Sedláček, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 1 | |
| 9 | 2018 | 6 | |
| 10 | 2018 | 10 | |
| 11 | 2018 | 20 | |
| 12 | 2017 | 6 | |
| 13 | 2010 | 42 | |
| 14 | 2010 | 21 | |
| 15 | 2009 | 15 | |
| 16 | 2007 | 4 | |
| 17 | 2005 | 58 | |
| 18 | 2005 | 3 | |
| 19 | 2001 | 13 | |
| 20 | 2001 | 1 |
About Petr Sedláček
Petr Sedláček is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 110 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (38 papers), Acute Lymphoblastic Leukemia research (35 papers), Chronic Myeloid Leukemia Treatments (27 papers), Acute Myeloid Leukemia Research (22 papers), Chronic Lymphocytic Leukemia Research (16 papers), Cytomegalovirus and herpesvirus research (13 papers), Immune Cell Function and Interaction (9 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). The work is most often cited by research in Hematology (867 citations), Genetics (250 citations) and Public Health, Environmental and Occupational Health (467 citations). Petr Sedláček has collaborated with scholars based in Czechia, Germany and France. Frequent co-authors include Jan Starý, Renata Formánková, Jan Trka, Marc Bierings, Petr Hubáček, Eva Froňková, Petr Cetkovský, Ester Mejstříková, Jan Zuna and Paul Veys. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Pediatric Transplantation and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.